News from unigene laboratories, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 14, 2013, 08:31 ET

Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update

 Unigene Laboratories, Inc. (PINK: UGNE) today announced financial results for the first quarter ended March 31, 2013 and provided a corporate...

May 09, 2013, 08:33 ET

Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs

 Unigene Laboratories, Inc. (PINK: UGNE), a leader in the design and development of peptide-based therapeutics, today announced it has entered...

Apr 17, 2013, 17:16 ET

Victory Park Capital Completes Public Auction of Unigene's Peptelligence™ Drug Delivery Platform

 Unigene Laboratories, Inc. (PINK: UGNE), today announced that on April 16, 2013, Victory Park Capital Advisors, LLC (VPC) held a public...

Apr 08, 2013, 08:33 ET

- Unigene Secures Financing to Extend Operating Runway in Conjunction with Strategic Reorganization -

Unigene Laboratories, Inc. (PINK: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Mar 11, 2013, 19:12 ET

Unigene Announces Fourth Quarter and Full-Year 2012 Results

Unigene Laboratories, Inc. (PINK: UGNE) today announced financial results for the fourth quarter and full-year ended December 31, 2012 and provided...

Mar 06, 2013, 16:56 ET

Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin

 Unigene Laboratories, Inc. (PINK: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Feb 13, 2013, 09:31 ET

Unigene Receives 2013 Drug Delivery Partnerships Industry Achievement Award

 Unigene Laboratories, Inc. (PINK: UGNE) today announced that for the second year in a row it has received the Drug Delivery...

Feb 07, 2013, 08:33 ET

Unigene to Present at the 17th Annual Drug Delivery Partnerships Meeting

 Unigene Laboratories, Inc. (PINK: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Jan 31, 2013, 17:16 ET

Unigene Completes Financial Statement Amendment

Unigene Laboratories, Inc. (PINK: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Jan 15, 2013, 11:06 ET

Unigene Welcomes FDA Advisory Committee Review of Salmon Calcitonin

Unigene Laboratories, Inc. (PINK: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Dec 12, 2012, 08:02 ET

Unigene's Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone

 Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Dec 11, 2012, 08:02 ET

Unigene Engages Financial Advisor to Explore Strategic Options and Advance Corporate Objectives

 Unigene Laboratories, Inc. (OTCBB: UGNE) today announced that it has retained Canaccord Genuity to assist the Company with its exploration and...

Nov 27, 2012, 08:02 ET

Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127

Unigene Laboratories, Inc. (OTCBB: UGNE) and Tarix Pharmaceuticals today announced that the companies have entered into a definitive licensing...

Nov 20, 2012, 09:06 ET

Unigene Announces Third Quarter 2012 Corporate Update

 Unigene Laboratories, Inc. (OTCBB: UGNE) today provided a corporate review on key development programs and strategic initiatives, including...

Nov 16, 2012, 09:40 ET

Unigene to Announce Third Quarter 2012 Financial Results on November 20, 2012

 Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics,...

Oct 16, 2012, 08:58 ET

Unigene's Licensee, Tarsa Therapeutics, Reports Positive Clinical Data in Phase 2 Study of Oral Calcitonin for Prevention of Postmenopausal Osteoporosis

 Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Oct 15, 2012, 08:02 ET

Unigene's Oral PTH Program Featured at ASBMR 2012 Annual Meeting

Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Sep 26, 2012, 08:32 ET

Unigene to Target Partnering and Therapeutic Development Opportunities Following Victory Park Capital Debt Financing and Forbearance

Unigene Laboratories, Inc. (OTCBB: UGNE), today announced the Company has entered into a Forbearance Agreement and First Amendment to Amended and...

Sep 20, 2012, 10:30 ET

Unigene To Present at the 2012 Obesity Society's 30th Annual Scientific Meeting

 Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today...

Sep 19, 2012, 08:02 ET

Unigene and Tarix Pharmaceuticals Report Highly Increased Oral Bioavailability of "Peptelligence-engineered" TXA127

 Unigene Laboratories, Inc. (OTCBB: UGNE) and Tarix Pharmaceuticals today announced the successful completion of a feasibility study of an oral...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge